Risk of restless legs syndrome in low socioeconomic rheumatoid arthritis patients

Modern Rheumatology

Volumn 23, Issue 4, 2013, Pages 705-708

  Ishaq, Muhammad ^a   Sualeh Muhammad, Jibran ^a,b   Hameed, Kamran ^c  

^a JINNAH MEDICAL AND DENTAL COLLEGE   (Pakistan)

^b AGA KHAN UNIVERSITY MEDICAL COLLEGE   (Pakistan)

^c ZIAUDDIN MEDICAL UNIVERSITY   (Pakistan)

Author keywords

Obesity; Restless leg syndrome; Rheumatoid arthritis; Socioeconomic

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PAKISTAN; PATIENT; POPULATION; PRIORITY JOURNAL; RESTLESS LEGS SYNDROME; RHEUMATOID ARTHRITIS; RHEUMATOID ARTHRITIS PATIENT; RISK ASSESSMENT; RISK FACTOR; SMOKING; SOCIOECONOMICS;

EID: 84880814506     PISSN: 14397595     EISSN: 14397609     Source Type: Journal    
DOI: 10.1007/s10165-012-0714-x     Document Type: Article

References (22)

1. O'Keeffe ST. Restless legs syndrome. A review. Arch Intern Med. 1996;156:243-8.
2. Kushida CA. Clinical presentation, diagnosis, and quality of life issues in restless legs syndrome. Am J Med. 2007;120(Suppl 1):S4-12.
3. Winkelmann J, Czamara D, Schormair B, Knauf F, Schulte EC, et al. Genome-Wide Association Study Identifies Novel Restless Legs Syndrome Susceptibility Loci on 2p14 and 16q12.1. PLoS Genet. 2011;7(7):e1002171. doi: 10.1371/journal.pgen.1002171.
4. Ohayon MM, et al. Epidemiology of restless legs syndrome: a synthesis of the literature. Sleep Med Rev. 2011;. doi: 10.1016/j.smrv.2011.05.002.
5. Sikandar R, Khealani BA, Wasay M. Predictors of restless legs syndrome in pregnancy: a hospital based cross sectional survey from Pakistan. Sleep Med. 2009;10(6):676-8.
6. Ishaq M, Muhammad JS, Hameed K, Mirza AI. Leflunomide or methotrexate? Comparison of clinical efficacy and safety in low socio-economic rheumatoid arthritis patients. Mod Rheumatol. 2011;21:375-80.
7. Farooqi AZ, Gibson T. Prevalence of major rheumatic disorders in the adult population of northern Pakistan. Br J Rheum. 1998;37:491-5.
8. Gudbjörnsson B, Broman JE, Hetta J, Hällgren R. Sleep disturbances in patients with primary Sjögren's syndrome. Br J Rheumatol. 1993;32:1072.
9. Hassan N, Pineau CA, Clarke AE, et al. Systemic lupus and risk of restless legs syndrome. J Rheumatol. 2011;38:874.
10. Yunus MB, Aldag JC. Restless legs syndrome and leg cramps in fibromyalgia syndrome: a controlled study. BMJ. 1996;312:1339.
11. Salih AM, Gray RE, Mills KR, Webley M. A clinical, serological and neurophysiological study of restless legs syndrome in rheumatoid arthritis. Br J Rheumatol. 1994;33:60.
12. Taylor-Gjevre RM, Gjevre JA, Skomro R, Nair B. Restless legs syndrome in a rheumatoid arthritis patient cohort. J Clin Rheumatol. 2009;15:12-5.
13. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO III, et al. Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis. 2010;69:1580-8.
14. Allen RP, Picchietti D, Hening WA, Trenkwalder C, Walters AS, Montplaisi J. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4(2):101-19.
15. Gao X, Schwarzschild MA, Wang H, Ascherio A. Obesity and resles legs syndrome in men and women. Neurology. 2009;72:1255-61.
16. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160:2137-41.
17. Winkelman JW. Considering the causes of RLS. Eur J Neurol. 2006;13(Suppl 3):8-14.
18. Kunas RC, McRae A, Kesselring J, Villiger PM. Antidopaminergic antibodies in a patient with complex autoimmune disorder and rapidly progressing Parkinson's disease. J Allergy Clin Immunol. 1995;96:688-90.
19. Ballok DA, Earls AM, Krasnik C, Hoffman SA, Sakic B. Autoimmune-induced damage of midbrain dopaminergic system in lupus-prone mice. J Neuroimmunol. 2004;152:82-97.
20. Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the Risk of Restless Legs Syndrome in the General Population. Arch Intern Med. 2004; 164:196-20.
21. Phillips B, Young T, Finn L, Asher K, Hening WA, Purvis C. Epidemiology of restless legs symptoms in adults. Arch Intern Med. 2000;160(14):2137.
22. Hornyak M, Trendwalder C, Kohnen R, Scholz H. Efficacy and safety of dopamine agonists in restless legs syndrome. Sleep Med. 2012;. doi: 10.1016/j.sleep.2011.09.013.